title: Odanacatib in postmenopausal women with low bone mineral density: a review of current clinical evidence.
abstract: Human bones are in a continuous process of remodeling that ensures renovation and maintenance of the skeletal mass. Bone remodeling has two phases that are normally coupled and balanced: bone resorption mediated by osteoclasts and bone formation mediated by osteoblasts. An increase in bone resorption over bone formation results in a progressive loss of bone mass and impairment of bone microarchitecture leading to osteoporosis and its associated fractures. Recent advances in the understanding of the molecular and cellular mechanisms involved in the remodeling process have allowed the development of new targets for osteoporosis treatment. Cathepsin K, a cysteine protease, is found in osteoclasts along the bone resorption surfaces and very efficiently degrades type I collagen, the major component of the organic bone matrix. Inhibition of cathepsin K reduces bone resorption but does not impair bone formation particularly at cortical sites. Odanacatib, a potent and highly selective cathepsin K inhibitor, showed prevention of bone loss without reduction of bone formation in preclinical and clinical trials (phase I and II). Odanacatib is currently in a phase III fracture outcome international trial for the treatment of postmenopausal osteoporosis.
authors.affiliation: Department of Rheumatology, Hospital Heliópolis, São Paulo, SP 04231-030, Brazil.
authors.forename: Cristiano A F
authors.initials: CA
authors.lastname: Zerbini
authors.forename: Michael R
authors.initials: MR
authors.lastname: McClung
keywords: animal models; bone demineralization; bone density conservation agents; bone remodeling; cathepsin K; osteoporosis postmenopausal; pathologic
references.citation: J Clin Endocrinol Metab. 2011 Apr;96(4):972-80
references.pmid: 21289258
references.citation: J Biol Chem. 1996 May 24;271(21):12517-24
references.pmid: 8647860
references.citation: Ann N Y Acad Sci. 2006 Apr;1068:165-72
references.pmid: 16831915
references.citation: J Bone Miner Res. 2012 Mar;27(3):524-37
references.pmid: 22113921
references.citation: Toxicol Pathol. 2002 May-Jun;30(3):312-21
references.pmid: 12051548
references.citation: Gene. 2009 Oct 15;446(2):90-8
references.pmid: 19563866
references.citation: Drug Metab Dispos. 2011 Jun;39(6):1079-87
references.pmid: 21422190
references.citation: Nat Rev Rheumatol. 2010 Feb;6(2):99-105
references.pmid: 20125177
references.citation: Bone. 2009 Feb;44(2):199-207
references.pmid: 18845279
references.citation: Bone. 2011 Dec;49(6):1351-6
references.pmid: 21982869
references.citation: Osteoporos Int. 2007 May;18(5):659-69
references.pmid: 17206399
references.citation: Science. 1996 Aug 30;273(5279):1236-8
references.pmid: 8703060
references.citation: Bone. 2011 Apr 1;48(4):677-92
references.pmid: 21145999
references.citation: Biol Chem. 2009 Sep;390(9):941-8
references.pmid: 19453281
references.citation: Bone. 2001 Mar;28(3):282-9
references.pmid: 11248658
references.citation: J Med Chem. 2005 Dec 1;48(24):7535-43
references.pmid: 16302795
references.citation: J Bone Miner Res. 2003 Feb;18(2):222-30
references.pmid: 12568399
references.citation: Bone. 2000 Mar;26(3):241-7
references.pmid: 10709996
references.citation: Bone. 2011 Oct;49(4):623-35
references.pmid: 21718816
references.citation: FASEB J. 2011 Oct;25(10):3366-76
references.pmid: 21705669
references.citation: N Engl J Med. 2001 May 10;344(19):1434-41
references.pmid: 11346808
references.citation: Curr Pharm Des. 2007;13(4):387-403
references.pmid: 17311556
references.citation: J Am Acad Dermatol. 2012 Mar;66(3):e89-96
references.pmid: 21571394
references.citation: J Med Chem. 2006 Mar 9;49(5):1597-612
references.pmid: 16509577
references.citation: Bioorg Med Chem Lett. 2008 Feb 1;18(3):923-8
references.pmid: 18226527
references.citation: J Bone Miner Res. 2004 Sep;19(9):1432-40
references.pmid: 15312243
references.citation: Future Med Chem. 2009 Apr;1(1):21-34
references.pmid: 20126511
references.citation: J Bone Miner Res. 2011 Jun;26(6):1303-12
references.pmid: 21312264
references.citation: J Bone Miner Res. 2010 May;25(5):937-47
references.pmid: 19874198
references.citation: J Bone Miner Res. 2011 Feb;26(2):252-62
references.pmid: 20734451
references.citation: J Bone Miner Res. 2011 Feb;26(2):242-51
references.pmid: 20740685
references.citation: Clin Pharmacol Ther. 2009 Aug;86(2):175-82
references.pmid: 19421185
references.citation: Bioorg Med Chem Lett. 2010 Feb 1;20(3):887-92
references.pmid: 20061146
references.citation: Clin Cancer Res. 2006 Feb 15;12(4):1221-8
references.pmid: 16489077
references.citation: Am J Pathol. 2001 Dec;159(6):2167-77
references.pmid: 11733367
references.citation: Clin Pharmacokinet. 2005;44(6):551-70
references.pmid: 15932344
references.citation: Genomics. 1997 Apr 15;41(2):169-76
references.pmid: 9143491
references.citation: Osteoporos Int. 2011 Dec;22(12):3001-11
references.pmid: 21308366
references.citation: J Bone Miner Res. 2012 Mar;27(3):509-23
references.pmid: 22113859
references.citation: Calcif Tissue Int. 2009 Oct;85(4):344-55
references.pmid: 19763376
references.citation: Cancer Res. 1997 Dec 1;57(23):5386-90
references.pmid: 9393764
references.citation: Curr Mol Med. 2002 Aug;2(5):407-21
references.pmid: 12125807
references.citation: J Biol Chem. 1998 Nov 27;273(48):32347-52
references.pmid: 9822715
references.citation: J Clin Endocrinol Metab. 2006 Nov;91(11):4520-7
references.pmid: 16912123
references.citation: J Clin Invest. 1998 Aug 1;102(3):576-83
references.pmid: 9691094
references.citation: J Bone Miner Res. 2012 Nov;27(11):2251-8
references.pmid: 22777865
references.citation: Chembiochem. 2006 Oct;7(10):1525-35
references.pmid: 16921579
references.citation: Bone. 2007 Jan;40(1):122-31
references.pmid: 16962401
references.citation: Bone. 2006 Jun;38(6):769-77
references.pmid: 16337236
references.citation: J Bone Miner Res. 1999 Oct;14(10):1654-63
references.pmid: 10491212
references.citation: Hum Mol Genet. 2007 Feb 15;16(4):410-23
references.pmid: 17210673
references.citation: Nat Rev Rheumatol. 2011 Jun 14;7(8):447-56
references.pmid: 21670768
references.citation: Bone. 2008 Jan;42(1):200-11
references.pmid: 17962093
references.citation: Osteoporos Int. 2010 Jun;21(6):1041-5
references.pmid: 19597911